Women and Testosterone Therapy: More Research Needed
Given the unapproved status of testosterone for women in the U.S., it is virtually impossible to track the number of prescriptions dispensed specifically for this purpose.
Given the unapproved status of testosterone for women in the U.S., it is virtually impossible to track the number of prescriptions dispensed specifically for this purpose.
Serious side effects and mislabeling are some of the most common lawsuit claims against defective drugs.
Research finds statewide opioid monitoring systems can reduce overprescribing and potential abuse.
Current regulations may not be adequate to cover pertinent legal issues raised by these technologies.
Rite Aid and Ohio counties reach opioid settlement deal.
Judge disappointed after hearing Endo may have withheld ‘smoking gun’ evidence.
Life-saving Epipens have skyrocketed in price over the years.
Richard Sackler replies ‘I don’t know’ when asked about personal involvement in the opioid crisis.
Purdue’s trial is given a specific amount of time.
Judge decides to cap lawyers’ fees in multidistrict opioid litigation.